PMC:7408073 / 26884-27114 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1037","span":{"begin":168,"end":172},"obj":"Gene"},{"id":"1038","span":{"begin":202,"end":206},"obj":"Gene"},{"id":"1045","span":{"begin":192,"end":200},"obj":"Gene"},{"id":"1059","span":{"begin":161,"end":167},"obj":"Gene"},{"id":"1067","span":{"begin":50,"end":57},"obj":"Disease"},{"id":"1068","span":{"begin":58,"end":78},"obj":"Disease"}],"attributes":[{"id":"A1037","pred":"tao:has_database_id","subj":"1037","obj":"Gene:185"},{"id":"A1038","pred":"tao:has_database_id","subj":"1038","obj":"Gene:116511"},{"id":"A1045","pred":"tao:has_database_id","subj":"1045","obj":"Gene:284"},{"id":"A1059","pred":"tao:has_database_id","subj":"1059","obj":"Gene:24179"},{"id":"A1067","pred":"tao:has_database_id","subj":"1067","obj":"MESH:D000860"},{"id":"A1068","pred":"tao:has_database_id","subj":"1068","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These reciprocal inhibitions in some cases (e.g., hypoxia/SARS-CoV-2 infection) can give rise to positive feedback loops that markedly shift the balance between Ang II/AT1R and the antagonist Ang (1–7)/MasR pathway (see Figure 1)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T171","span":{"begin":58,"end":66},"obj":"Disease"},{"id":"T172","span":{"begin":58,"end":62},"obj":"Disease"},{"id":"T173","span":{"begin":69,"end":78},"obj":"Disease"}],"attributes":[{"id":"A171","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A172","pred":"mondo_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A173","pred":"mondo_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"These reciprocal inhibitions in some cases (e.g., hypoxia/SARS-CoV-2 infection) can give rise to positive feedback loops that markedly shift the balance between Ang II/AT1R and the antagonist Ang (1–7)/MasR pathway (see Figure 1)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T233","span":{"begin":161,"end":164},"obj":"Chemical"},{"id":"T234","span":{"begin":165,"end":167},"obj":"Chemical"},{"id":"T235","span":{"begin":181,"end":191},"obj":"Chemical"},{"id":"T236","span":{"begin":192,"end":195},"obj":"Chemical"}],"attributes":[{"id":"A233","pred":"chebi_id","subj":"T233","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A234","pred":"chebi_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A235","pred":"chebi_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A236","pred":"chebi_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"These reciprocal inhibitions in some cases (e.g., hypoxia/SARS-CoV-2 infection) can give rise to positive feedback loops that markedly shift the balance between Ang II/AT1R and the antagonist Ang (1–7)/MasR pathway (see Figure 1)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T125","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These reciprocal inhibitions in some cases (e.g., hypoxia/SARS-CoV-2 infection) can give rise to positive feedback loops that markedly shift the balance between Ang II/AT1R and the antagonist Ang (1–7)/MasR pathway (see Figure 1)."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T52","span":{"begin":50,"end":57},"obj":"Phenotype"}],"attributes":[{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0012418"}],"text":"These reciprocal inhibitions in some cases (e.g., hypoxia/SARS-CoV-2 infection) can give rise to positive feedback loops that markedly shift the balance between Ang II/AT1R and the antagonist Ang (1–7)/MasR pathway (see Figure 1)."}